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Abstract  
Epicardial adipose tissue (EAT), which is thought to be a component of visceral adiposity, is associated with the 
metabolic syndrome and considered as an indicator of cardiovascular risk. Correlation of EAT with coronary 
artery disease (CAD) in Indonesia is unknown. To address this issue, we examined the relationship between 
EAT thickness with severity of coronary lesion in Indonesian patients with CAD. Results revealed that one 
hundred and thirty one consecutive patients who underwent transthoracic echocardiography (TTE) and 
diagnostic coronary angiography were studied. The EAT thickness on the free wall of the right ventricle was 
measured at end-diastole from the parasternal long-axis views. Coronary angiograms were analyzed for severity 
of coronary artery disease using modified Gensini score. Accordingly, we classified the study population into 
two angiographic groups: patients with non-severe CAD (Gensini score ≤13) and patients with severe CAD 
(Genisini score >13). There were no significant differences between the groups with respect to anthropometric 
measurements, including body mass index and waist circumference (p=0.473 and 0.947, respectively). 
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The patients in severe CAD group had greater EAT thickness compared with non-severe CAD group (mean 
EAT thickness was 8.5±2.4 mm and 6.1±2.5 mm, respectively with p<0.001).EAT thickness of >7.0 mm had an 
78.2 % sensitivity and an 71.7% specificity (ROC area of 0.800, p<0.001, 95% CI [0.72-0.88] for predicting 
severe CAD. In conclusions EAT thickness was significantly correlated with the severity of CADin Indonesian 
patients with stable CAD. 
Keywords: epicardial adipose tissue; coronary artery disease; echocardiography; Indonesia. 
1. Introduction 
Cardiovascular disease (CVDs) is the number one cause of death globally; more people die annually from CVDs 
than from any other cause. An estimated 17.3 million people died from CVDs in 2008, representing 30% of all 
global death [1]. Of these deaths, an estimated 7.3 million were due to coronary artery disease (CAD) [2]. 
Inflammation plays an integral role in the pathogenesis of atherosclerotic CAD [3-5]. Therefore the interest in 
the EAT that is located between the myocardium and the pericardium surrounding both ventricles with variable 
extent and distribution patterns arouse [6-8].  Because of its endocrine and paracrine activity, secreting pro-
inflammatory and anti-inflammatory cytokines and chemokines, it has been suggested to influence coronary 
atherosclerosis development [9-13]. 
TTE enables non-invasive assessment of EAT [14,15]. To date, the correlation of EAT with severity of CAD in 
Indonesia remains unknown. To address this issue, we examined the relationship between EAT thickness 
measured by transthoracic echocardiography with severity of CAD in Indonesian patients with stable CAD. 
2. Materials and Methods 
2.1 Study Design 
The study was designed as an observational cross-sectional study. The study was approved by Hasanuddin 
University ethic committee and written informed consent was obtained from all participants. 
2.2 Patients 
We studied 131 consecutive patients who had undergone coronary angiography from July 2015 through March 
2016 because of clinical diagnoses of stable CAD. The prospective study was performed in a single tertiary 
center. Patient with acute coronary syndrome, severe heart failure (New York Heart Association Class III-IV), 
poor echocardiographic images, severe valvular pathologic condition, and chronic kidney disease were 
excluded.   
Patients were defined as hypertensive (JNC VII Guidelines), if they had a systolic pressure greater than 140 
mmHg or a diastolic pressure greater than 90 mmHg, or if they were being treated with an antihypertensive 
medication. Patients were considered to have type II diabetes mellitus if they were previously diagnosed or 
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following the 2010 American Diabetes Association (ADA) diabetes diagnostic criteria, or if the patients were 
being treated with antidiabetic medication. Whereas dyslipidemia was defined from the NHLBI ATP III 
prevention guidelines, or the subjects were being treated with a lowering lipid medication. 
2.3 Echocardiography  
Transthoracic echocardiographic (TTE) examinations were performed using a Vivid 7®cardiac ultrasound 
system (GE Medical Systems; Horten, Norway) with a 2.5- to 3.5-MHz transducer with patients in the left 
lateral decubitus position. We measured EAT thickness on the free wall of right ventricle from the parasternal 
long-axis views. EAT was identified as an echo-free space in the pericardial layers on the 2-dimensional 
echocardiography, and its thickness was measured perpendicularly on the free wall of the right ventricle at end-
diastole [15,16]. As illustrated in Figure 1. EAT thickness was measured at end-diastole from parasternal long- 
and short-axis B mode still-frame images by two echocardiographers who were blinded to coronary angiography 
data. Parasternal long- and short-axis measurements were averaged to obtain the mean thickness.  
2.4 Coronary Angiography 
Selective coronary angiography was applied to all patients with Judkins technique. Angiograms were recorded 
in multiple projections with a biplanar digital cardiac imaging system (Philips Integris DCI, Eindhoven, the 
Netherlands). Cine angiograms were evaluated by two experienced cardiologists. By examining all of the 
coronary angiograms, the localization and luminal stenosis rate of all coronary artery lesions were identified. 
The severity of coronary artery lesions was scored using a modified Gensini score [17,18]. In brief, the coronary 
circulation was divided into eight proximal segments; the percentage by which each lesion in the proximal 
coronary circulation narrowed the artery was assessed according to the maximal narrowing of the diameter of 
the artery in all projections. The extent and severity of proximal coronary disease was assessed by assigning 
points to each lesion  as follows: less than 50% of the luminal diameter, 1 point; 50% to 74% stenosis, 2 points; 
75% to 99% stenosis, 3 points, and total obstruction, 4 points. The points of each lesion in the proximal 
coronary circulation were summed and a score for severity of coronary atherosclerosis was obtained. According 
to the modified Gensini score for classification of the degree of coronary stenosis [19]; the results of total scores 
can be separated into mild lesions (1-6 points), moderate lesions (7-13 points), and severe lesions (>13 points). 
Accordingly, we classified the study population into two angiographic groups: patients with non-severe CAD 
(Gensini score ≤13) and patients with severe CAD (Genisini score >13). 
2.5 Statistical analyses 
Continuous variables are expressed as means±standard deviation. Categorical variables were compared with the 
chi-square test. The Pearson correlation analysis was used to determine the relationship between mean values. 
The cut-off value of EAT thickness for predicting severe CAD with corresponding specificity and sensitivity 
was estimated by receiver operating characteristic (ROC) curve analysis. A pvalue of less than 0.05 was 
considered statistically significant. SPSS software (Statistical Package for the Social Sciences, version 21.0, 
SSPS Inc., Chicago, IL, USA) was used for all statistical calculations. 
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Figure 1: Example of measurenment of epicardial adipose tissue thickness. Epicardial adipose tissue was 
identified as an echo-free space in the pericardial layers on the 2-dimensioanl echocardiography and its 
thickness was measured perpendicularly on the free wall of the right ventricle at end-diastole. 
3. Results 
3.1 Demographic and Echocardiographic Characteristics of Study Population 
There were 100 male and 31 female in the study population. The mean age was 57.0±8.0 years. The 
demographic and echocardiographic data of study groups are presented in Table 1. Patients with severe CAD 
were significantly more male smoker and had lower ejection fraction than were patients with non-severe CAD. 
Mean EAT thickness was 6.1±2.5 mm in the non-severe CAD group and 8.5±2.4 mm in the severe CAD group 
(p<0.001). There were no significant differences between the groups with respect to anthropometric 
measurements, including body mass index and waist circumference. 
3.2 Relationship between EAT Thickness with CAD Severity 
Analysis of the relationship between EAT thickness with severity of CAD measured by Gensini score showed 
that a positive linear relationship for the entire subjects (R2=19.6%; Figure 2).  The thickness of EAT was 
increased in those with severe CAD in comparison to those with non-severe CAD (Figure 3). 
 
Figure 2: Scatter plot illustrating the relationship between epicardial adipose tissue thickness and Gensini score. 
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Table 1: Demographic and echocardiographic characteristics of subjects by study groups 
Variable (n=131) Non-severe CAD (n=78) Severe CAD (n=53) p value 
Demographic characteristics 
Age (years) 55.9±7.9 57.9±7.3 0.137 
Gender (male/female) 51/27 49/4 <0.001 
BMI (kg/m2) 25.2±4.4 24.7±2.8 0.473 
Waist circumference (cm) 91.3±13.2 91.5±11.9 0.947 
Hypertension, n(%) 30 (53.6) 26 (46.4) 0.306 
Smoker, n(%) 33 (49.3) 34 (50.7) 0.023 
Diabetes mellitus, n(%) 13 (46.4) 15 (53.6) 0.168 
Dyslipidemia, n(%) 73 (60.3) 48 (39.7) 0.375 
Family history, n(%) 6 (54.5) 5 (45.5) 0.480 
Echocardiographic characteristics 
Ejection fraction (%) 60.7±8.7 57.2±7.4 0.019 
EAT thickness (mm) 6.1±2.5 8.5±2.4 <0.001 
Values are presented as mean±standard deviation or number (%).  
EAT,epicardial adipose tissue. 
 
Figure 3: Box and whisker diagram illustrating the relationship between Epicardial adipose tissue thickness and 
severity of coronary artery disease. 
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3.3 EAT Thickness as Predictor of CAD Severity 
EAT thickness of >7.0 mm had an 78.2 % sensitivity and an 71.7% specificity (ROC area of 0.800, p<0.001, 
95% CI [0.72-0.88] for predicting severe CAD); Figure 4, Table 2.  
 
Figure 4: Receiver operating characteristic curve of the epicardial adipose tissue thickness in predicting severe 
coronary artery disease. 
Table 2: Predictor of coronary artery disease severity by epicardial adipose tissue thickness 
Predictor Accuracy Cutoff Sensitivity Specificity  PPV NPV p 
EAT 80.0% >7.0 mm 78.2% 71.7% 80.3% 69.1% <0.001 
PPV, positive predictive value; NPV, negative predictive value 
4. Discussion 
To the best of our knowledge, this is the first study to analyze the relationship between EAT thickness and CAD 
severity in Indonesia. This study shows an association between EAT thickness measured by TTE and the 
severity of CAD.  
Until now, magnetic resonance imaging (MRI) has been accepted as a gold standard for measuring EAT 
thickness. In 2003, Iacobellis and his colleagues first reported the development of the echocardiographic 
measurement of EAT. They showed that echocardiographic EAT thickness has good correlation with MRI 
abdominal, epicardial fat measurements, anthropometric and metabolic parameters [15,16]. 
Our result showed that patients with severe CAD measured by Gensini score had thicker EAT compared with 
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patient with non-severe CAD. Two potential mechanisms for this association have been proposed. First, EAT is 
a component of visceral adiposity and is related to metabolic syndrome and cardiovascular risk factors. 
Secondly, it has paracrine and endocrine functions. Sacks and his colleagues pointed out the paracrine and 
vasocrine signaling effects of epicardial adipokines for the development of atherogenesis [14,16,20,21]. 
Furthermore, we found that there were no significant differences between the groups with respect to body mass 
index and waist circumference. This finding highlights the importance of visceral adiposity but not total 
adiposity with respect to cardiovascular risk. Thickness in EAT is also associated with metabolic syndrome [22], 
insulin resistance [23], endothelial dysfunction [24], and overt atherosclerotic CAD [25].Clinical observations 
suggest that proximal portions of the coronary arteries are more deeply embedded in epicardial fat than are distal 
portions and are thus more susceptible to atherosclerosis. This has been attributed to the relative paucity of 
periadventitial adipose tissue, which is in continuity with the epicardial adipose tissue. 
Epicardial adipose tissue produces miscellaneous proinflammatory and proatherogenic mediators, including 
interleukin-6, interleukin-1, tumor necrosis factor-α, monocyte chemoattractant protein-1, plasminogen activator 
inhibitor-1, angiotensinogen, leptin, resistin, and visfatin. On the other hand, adiponectin, which exerts an 
antiatherogenic effect via the improvement of endothelial function and the mitigation of inflammation, has been 
shown to be under expressed in the EAT of patients who have CAD [26-28]. 
Gökdeniz and associates analyzed relationship of EAT thickness to the CAD complexity in non-diabetic 
subjects. They found EAT thickness to be significantly correlated to SYNTAX score (r =0.629; p<0.001). They 
also determined a cutoff value of 5 mm EAT thickness for the prediction of an intermediate to high SYNTAX 
score (ROC area of 0.851, 95% CI [0.77–0.91] at a specificity of 92.2% and a sensitivity of 77.4%.However, 
those investigators studied non-diabetic patients only, whereas we analyzed the relationship of EAT thickness 
with CAD severity in a diabetic and non-diabetic population [29]. They analyzed the severity of CAD by 
SYNTAX score, whereas we used Gensini score. 
5. Limitation 
Our analysis was limited by the studied population because it included only those patients pre-selected to 
undergo coronary angiography. As non-invasive tools for the diagnosis of coronary artery disease have been 
developed, a population-based prospective study with a large number of patients can be performed. Therefore, 
an epidemiologic study is required to confirm these results. Serum levels of interleukins, cytokines, and 
adipokines, which could hint at the underlying mechanisms of atherosclerosis in CAD, were not evaluated 
6. Conclusion 
Our results could help identify severe CAD by transthoracal echocardiography-relatively inexpensive and 
readily available- before coronary angiography, thereby indicating whether early invasive coronary angiography 
and timely interventions should be performed especially in the setting where catheter lab resources are scant and 
waiting time for the examination is long. 
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